Experlytics proudly announces the release of a bespoke electronic data capture platform with pioneering analytical tools for Lund Melanoma Study Group (LMSG). The platform will manage all data capture for the BioMEL project for a duration of 5 + years. Apart from being one of the most complex productions undertaken by Experlytics, the platform incorporates novel features such as a cross platform statistical viewer and an artificial intelligence powered factor weighting analytics tool.
Mattias Paulsson, CEO of Experlytics, will participate as a jury member in the KPMG International Case Competition in Lund on the 26th of November. The competition is the Swedish national competition and is open to qualified teams from the a selection of universities in Sweden.